About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Diabetes Clinical Trials in Colorado | 29 Studies

Clinical Trials DiabetesColorado

Diabetes Clinical Trials in Colorado

Find 29 clinical trials for diabetes near Colorado. Connect with research centers in your area.

All Diabetes trials nationwide All trials in Colorado

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 29 trials

CompletedSafety of Inhaled Insulin With Type 1 and Type 2 DiabetesPulmonary Safety in Diabetics with T/INCT00308737·Phoenix, Arizona and 175 others

Page 1 of 2Next

Diabetes Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Enrolling by invitationT2D Intermittent Nonprescription Sensors for Informed Glucose Health TrackingThe goal of this clinical trial is to learn if periodic use of over-the-counter continuous glucose monitoring (CGM) can support glucose management in people with type 2 diabetes…NCT07422831·Aurora, Colorado

CompletedAn Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesThis is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace.NCT00229658·Birmingham, Alabama and 106 others

CompletedEfficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesThe purpose of this study is to evaluate the safety and effectiveness of alogliptin combined with metformin, once daily (QD) or twice daily (BID), in participants with Type 2…NCT01023581·Dothan, Alabama and 200 others

Active not recruitingEversense® Non-adjunctive Use Post Approval StudyThis is a non-blinded, prospective, multi-center, single arm longitudinal cohort study (patient serving as their own control), to evaluate the effectiveness of diabetes with the…NCT04836546·Los Angeles, California and 22 others

Active not recruitingGATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With DiabetesThe purpose of this study is to check that a new insulin pump, called NMX8, is safe when used with a continuous glucose monitoring sensor called Disposable Sensor 5/Simplera Sync…NCT07228117·Little Rock, Arkansas and 32 others

CompletedPost Approval Study of the Eversense® Continuous Glucose MonitoringA Post Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System over repeat insertion and removal cycles and…NCT03908125·Newport Beach, California and 16 others

CompletedPreclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept StudyThe goal of the study is to characterize preclinical Alzheimer's Disease and related dementias (AD/ADRD) neuropathology in a selected group of young adults with youth-onset…NCT05350514·Aurora, Colorado

CompletedClinical Trial of SB-509 in Subjects With Diabetic NeuropathyThe purpose of the study is to evaluate the clinical effects of the investigational drug, SB-509, in subjects with diabetic neuropathy.NCT01079325·Phoenix, Arizona and 30 others

CompletedStudy of a High-Dose Aflibercept in Participants With Diabetic Eye DiseaseThe primary objective of the study is to determine if treatment with high-dose aflibercept (HD) at intervals of 12 or 16 weeks provides non-inferior best corrected visual acuity…NCT04429503·Phoenix, Arizona and 137 others

CompletedFeasibility Study of New Subcutaneous Glucose Sensor With Recording DevicesThe purpose of Phase 3 Group is to evaluate the impact of acetaminophen on the performance of Guardian Sensor (3) during 11 days of wear (approximately 264 hours) in subjects with…NCT04020822·Aurora, Colorado and 1 other

RecruitingPrimary Care Pragmatic, Real World Experience for Automated Insulin DeliveryThe goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes…NCT07011147·Aurora, Colorado and 1 other

CompletedAdult Accuracy Study of the Enlite 3 Glucose SensorThe purpose of this study is to demonstrate the performance of the Enlite 3 Sensor over 168 hours (7 days) when inserted in the abdomen and used with the Guardian Mobile App and…NCT02246582·Escondido, California and 5 others

CompletedNurse Telephone Management of Cholesterol in DiabetesThe current project is evaluating the effect of a nurse-administered phone care in diabetes to improve access to care and healthcare delivery.NCT00950963·Denver, Colorado

TerminatedA Study in Participants With Diabetic Kidney DiseaseThe purpose of this study is to determine if LY2382770 is safe and effective at protecting kidney function in participants with kidney disease due to diabetes.NCT01113801·Phoenix, Arizona and 77 others

CompletedPROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 DaysThe purpose of this clinical investigation is to evaluate the accuracy of the Eversense® continuous Glucose Monitoring System (Eversense® 180 CGM System) measurements when…NCT03808376·Concord, California and 7 others

CompletedImpact of Acetaminophen on Performance of Guardian™ Sensor (3) in AdultsThe purpose of this study is to characterize the impact of acetaminophen ingestion on the performance of the Guardian™ Sensor (3) (i.e., C algorithm and Zeus algorithm) in…NCT04378114·Escondido, California and 5 others

CompletedA 2-Month Safety Follow-Up TrialThe main purpose of the trial is to evaluate pulmonary function in subjects who had completed any one of the 4 MKC parent trials (MKC-TI-009, MKC-TI-102, MKC-TI-103, or…NCT00741429·Birmingham, Alabama and 149 others

CompletedOmnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 DiabetesThe goal of this multi-center, randomized, cross-over study is to evaluate the safety and effectiveness of the Omnipod 5 SmartAdjust 2.0 System in individuals with type 1 or type…NCT06865989·Los Angeles, California and 10 others

CompletedEfficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in DiabeticsThis trial is conducted in the United States of America (USA).NCT00773279·Burlingame, California and 64 others

Other Conditions in Colorado

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia